ode study: 'Esophageal resection for patients with esophageal cancer and cervical lymph node metastases' - Node study

Heelkunde, chirurgie0 个研究点目标入组 20 人开始时间: 待定最近更新: 2024年4月23日

适应症

试验速览

暂无简介。

•- Histologically proven squamous cell carcinoma or adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus.
•- Surgical resectable carcinoma (T1-4a, N1-3)
•- Histologically/ cytologically proven resectable cervical lymph node metastases level III and/ or IV
•- Age >= 18
•- European Clinical Oncology Group (ECOG) performance status 0,1 or 2
•- Written informed consent

•- Distant metastases
•- Esophageal carcinoma < 3 cm beneath UES
•- Carcinoma of the gastro-esophageal junction (GEJ) with major tumor in the gastric cardia (Siewert III)
•- Former radiotherapy or chemotherapy for esophageal carcinoma
•- Former radiotherapy precluding radiotherapy according the CROSS protocol
•- Inadequate pulmonary function disabling transthoracic resection
•- Previous neck dissection
•- New York heart association class III/IV and no history of active angina. Patients with a history of significant ventricular arrhythmia requiring medication or congestive heart failure. History of 2nd or 3rd degree heart blocks

发起方

Heelkunde, chirurgie